Jaguar health announces import of coca leaf from peru by joint venture magdalena biosciences for research in treating adhd

Magdalena biosciences is focused on developing novel, natural prescription medicines derived from plants for mental health indications import of coca leaves was authorized by the peruvian health authority san francisco, ca / accesswire / september 21, 2023 / jaguar health, inc. (nasdaq:jagx) ("jaguar") today announced that magdalena biosciences, inc. ("magdalena"), the joint venture recently formed by jaguar and filament health corp. (otcqb:flhlf) (neo:fh) (fse:7qs) ("filament" or "filament health"), successfully completed an import of coca leaf to a filament facility (psilo scientific) in canada. image of coca leaves.
JAGX Ratings Summary
JAGX Quant Ranking